博雷頓(01333.HK)擬對上海佰頻進行增資擴股
格隆匯6月4日丨博雷頓(01333.HK)公告,於2025年6月4日,公司、公司全資附屬公司上海佰頻與上海易津訂立增資協議。據此,上海易津將出資人民幣2000萬元對上海佰頻進行增資擴股,上海佰頻的註冊資本擬由人民幣4000萬元增加到人民幣6,000萬元。本次增資完成後,公司對上海佰頻的持股比例將下降至約66.67%,上海佰頻將仍爲公司的附屬公司,仍計入集團合併財務報表。
本次增資符合公司及上海佰頻的戰略發展規劃,有助於上海佰頻增強資本實力、優化股權結構。此舉將進一步強化公司與上海佰頻的協同效應及支持力度,支持其實現海外業務化及全球化目標,提升獨立發展能力,並最終提升公司核心競爭力,推動長期高質量發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.